NCT00010426View on ClinicalTrials.gov

Randomized Study of New Formulation Ophthalmic Cysteamine Hydrochloride for Corneal Cystine Accumulation in Patients With Cystinosis

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 31, 1999

Study Completion Date

February 28, 2001

Conditions
Cystinosis
Interventions
DRUG

cysteamine hydrochloride

Sponsors
All Listed Sponsors
collaborator

Leadiant Biosciences, Inc.

INDUSTRY

lead

FDA Office of Orphan Products Development

FED

NCT00010426 - Randomized Study of New Formulation Ophthalmic Cysteamine Hydrochloride for Corneal Cystine Accumulation in Patients With Cystinosis | Biotech Hunter | Biotech Hunter